Carregant...
Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
Lung cancer remains the leading cause of cancer-related deaths worldwide. However, significant progress has been made individualizing therapy based on molecular aberrations (e.g., EGFR, ALK) and pathologic subtype. KRAS is one of the most frequently mutated genes in non-small cell lung cancer (NSCLC...
Guardat en:
| Publicat a: | Oncologist |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AlphaMed Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5153335/ https://ncbi.nlm.nih.gov/pubmed/27807303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0084 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|